Suchergebnisse - "D'Arena, Giovanni"

PubPharm (244)

41

Leg Type Primary Cutaneous Diffuse Large B-Cell Lymphoma

enthalten in: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion | 2019

von D'Arena, G. | Galdo, G. | Lalinga, V. | +4

42

Monoclonal B-cell lymphocytosis and prostate cancer : incidence and effects of radiotherapy

enthalten in: Journal of investigative medicine : the official publication of the American Federation for Clinical Research | 2019

von D'Auria, F. | Valvano, L. | Rago, L. | +5

43

Oxidative stress in chronic lymphocytic leukemia : still a matter of debate

enthalten in: Leukemia & lymphoma | 2019

von D'Arena, G. | Seneca, E. | Migliaccio, I. | +10

44

Leg Type Primary Cutaneous Diffuse Large B-Cell Lymphoma

enthalten in: Indian journal of hematology & blood transfusion | 2019

von D’Arena, G. | Galdo, G. | Lalinga, V. | +4

45

Thalidomide-induced psoriasis in a patient with multiple myeloma

enthalten in: Postgraduate medical journal | 2019

von D'Arena, G. | Galdo, G. | Musto, P.

46

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2019

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

47

Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanisms

enthalten in: OncoTargets and therapy | 2019

von Giudice, A. | Barbieri, A. | Bimonte, S. | +11

48

Leg Type Primary Cutaneous Diffuse Large B-Cell Lymphoma

enthalten in: Indian journal of hematology and blood transfusion | 2018

von D’Arena, G. | Galdo, G. | Lalinga, V. | +4

49

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

50

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25